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Key Clinical Message
In this study, we present the first case of a 34-year-old Surinamese female with
ischemic retinopathy and increased free protein S due to C4BP deficiency. Pos-
sibly, the low PS/C4BP complex level has increased the risk of arterial thrombo-
sis in our patient.
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Introduction
Protein S is a vitamin K-dependent protein that inhibits
coagulation by acting as a cofactor for both tissue factor
pathway inhibitor (TFPI) and activated protein C (APC).
Therefore, it is not surprising that a deficiency of protein
S predisposes to venous thrombosis. In this study, we
present for the first time a case of a 34-year-old Suri-
namese female with ischemic retinopathy. After the exclu-
sion of hypertension, diabetes mellitus, vasculitis,
hyperviscosity, and sickle cell disease, a thrombophilia
workup was performed, thereby discovering an increased
free protein S due to decreased complement component
C4-binding protein (C4BP) levels. A thrombophilia
workup was performed in the proband. In addition, free
protein S antigen and activity were measured in consecu-
tive samples. Free protein S antigen was also measured in
father and 1 brother. C4BP levels were measured with an
ELISA against the a-chain of C4BP. Next, direct sequenc-
ing analysis was performed on C4BPA (encoding C4BPa,
NM_000715), C4BPB (encoding C4BPb, NM_000716),
and the sex-hormone-binding globulin (SHBG)-like
region of protein S (NM_000313) in the proband. Conse-
quently, possible pathogenic mutations were screened in
father and brother to determine segregation. We found
increased free protein S and decreased C4BP levels in the
proband. Genetic analysis of protein S and C4BP did
reveal at least 1 potential pathogenic mutation in C4BPA
gene (p.R240H). This mutation was absent in both father
and brother who had normal free protein S levels. In this
study, we present for the first time a case of a 34-year-old
female with ischemic retinopathy and increased free pro-
tein S due to decreased C4BP levels. Genetic analysis of
protein S and C4BP did reveal at least one potential
pathogenic mutation in C4BPA gene. Additional screen-
ing for these mutations in father and one brother could
not exclude the possible association between C4BPA
p.R240H and decreased C4BP levels. Furthermore, it
remains unclear how the high protein S activity due to
decreased C4b-binding protein is related to the ischemic
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retinopathy in our patient. The protein S fraction bound
to C4BP may have some anticoagulant activity, as sug-
gested before. Maybe, the low PS/C4BP complex level has
increased the risk of arterial thrombosis in our patient.
Nonetheless, future studies are required on this issue.
Protein S is a vitamin K-dependent protein that inhi-
bits coagulation by acting as a cofactor for both tissue
factor pathway inhibitor (TFPI) accelerating the inhibi-
tion of activated factor Xa, and activated protein C
(APC) by forming lipid-bound complexes that accelerate
the inactivation of factor Va and factor VIIIa [1, 2]. Defi-
ciency of protein S predisposes to venous thrombosis.
In plasma, protein S is present in two forms, a free
fraction consisting of 40% of total protein S, which is
considered as the active form and the remaining fraction
bound to the b-chain of complement component C4-
binding protein (C4BP) [3]. Even though it is generally
accepted that only the free form of protein S has cofactor
activity, the protein S fraction bound to C4BP may have
some anticoagulant activity, as suggested before [4]. The
C4BP protein contains six or seven a-chains and one
b-chain linked by disulfide bridges. The a-chains are
responsible for binding C4b and the b-chain binds
protein S [5, 6]. Besides its indirect role in coagulation,
C4BP is also involved in regulating the classical and lectin
pathways of complement activation by binding activated
complement protein C4b [5]. During inflammation, the
expression of the a-chain increases, without a significant
rise in b-chain expression this insures that the level of
free protein S is not significantly affected during inflam-
mation [7].
Case Report
A 34-year-old Surinamese female was referred to the
Department of Vascular Medicine of our hospital because
of right-sided blurred vision, caused by ischemic
retinopathy and neovascularisation (Fig. 1). Her medical
history was remarkable for heterozygote alpha-thalasse-
mia, but negative for thrombotic and recurrent infectious
events. The family history was also negative for throm-
botic events or bleeding tendency. The patient was not
treated with anticoagulants or platelet inhibitors. Physical
examination was normal (BMI 23.0 kg/m2, blood pressure
125/70 mmHg, heart rate 85/min, normal heart sounds,
and no vascular murmurs). After the exclusion of hyper-
tension, diabetes mellitus, vasculitis, hyperviscosity, and
sickle cell disease, a thrombophilia workup was per-
formed. All hemostatic laboratory parameters were found
normal except for an increased protein S activity (179%)
with high free protein S level (207%), despite a normal
total protein S antigen level (98%) (Table 1). This sug-
gested that, in contrast to normal conditions, all protein
S was free protein S, instead of 30–40% free and 60–70%
(A) (B)
(C) (D)
Figure 1. Retinal images. Wide field fundus photography of the left (A) and right eye (B) of the patient showing white occluded vessels in the
retinal periphery and a retinal neovascularisation in the temporal superior arcade of the left eye (A), with some pre-retinal blood. Wide field
fluorescence angiography of the left (C) and right eye (D) shows large ischemic areas with complete obliteration of the peripheral retinal vessels in
both eyes and hyperfluorescence of the retinal neovascularisation in the left eye (C).
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bound protein S. High activity and antigen levels of free
protein S were confirmed in a separate sample 3 months
later. Clinically, a protein S deficiency is considered as a
possible cause of hypercoagulation, which in turn could
have led to the retinopathy. The incidental finding of ele-
vated protein S levels were not considered explanatory of
the condition. We did not initiate anticoagulation or
thrombocyte aggregation inhibition. The patient’s vision
did not improve remarkably, nor did it deteriorate in the
subsequent months after her initial visit.
The high free protein S level in the proband was caused
by a reduced level of C4BP (18%), as measured with an
ELISA against the a-chain of C4BP. To identify a possible
molecular defect underlying the C4BP deficiency, we
sequenced the protein-coding regions and exon/intron
boundaries of C4BPA (encoding C4BPa, NM_000715)
and C4BPB (encoding C4BPb, NM_000716).
We identified two previously reported non-synonymous
variants in C4BPA, that is, c.719G>A (p.R240H), rs45574833
((A=0.0140/1686 (ExAC), A = 0.0030/15 (1000 Genomes),
A = 0.0095/124 (GO-ESP), A = 0.0078/227 (TOPMED)),
and c.899T>C (p.I300T), rs4844573 (C = 0.4014/47780
[ExAC], C = 0.4898/2453 [1000 Genomes], C = 0.4841/6296
[GO-ESP], T = 0.4689/13653 [TOPMED]).
In addition, we screened the father and brother for
these mutations. Both are also Surinamese. Only p.I300T
was present in the father (Fig. 2). Both father and brother
had normal free protein S levels. Mother, second sister,
and second brother were unavailable for testing.
Discordant data concerning the association between
C4BP polymorphisms and atypical hemolytic uremic syn-
drome have been reported [8, 9]. Furthermore, these two
variants have also been identified in women experiencing
recurrent miscarriages, but due to equally high frequen-
cies between patients and controls, the importance of
these variants in this particular clinical situation may be
questionable [10]. No mutations were found in the
C4BPB gene.
Because we could not find clear molecular defect in the
C4BP gene responsible for the reduced expression, and a
recent report indicated that binding of protein S to C4BP
promotes cellular secretion of C4BP [11], we also
sequenced the sex hormone-binding globulin (SHBG)-like
region of protein S (NM_000313), responsible for binding
to C4BP using the previously published primers [12, 13].
No mutations explaining a reduced binding of protein S
to C4BP were found in the SHBG-domain of protein S.
Although the medical records did not report any use of
vitamin K antagonist, we excluded the interference of any
form of vitamin K antagonists by the measurement of
coagulation factors II, VII, and X which were all normal,
except for factor X which was slightly increased (163%)
(Table 1). Furthermore, there was no indication of
reduced capacity of liver synthesis with normal
antithrombin and factor V levels. Furthermore, we also
did not find a clear effect of decreased C4BP levels on the
complement route, with normal complement pathway
activities (Table 1).
Conclusion
We present for the first time a 34-year-old female with
ischemic retinopathy and incidental finding of increased
free protein S due to decreased C4BP levels. Additional





aPTT 24 23–33 sec
Fibrinogen 2.3 1.7–4.0 g/L
Antithrombin 91 80–120 %




Protein C activity 100 65–150 %
Protein S total 98 65–150 %
Protein S free 207 60–140 %
Protein S activity 179 65–150 %
C4BP 18 56–168 %
FII 140 60–140 %
FV 98 65–150 %
FVII 92 65–150 %
FX 163 65–150 %
Complement
Classical pathway 106 69–129 %
MBL pathway 122 70–130 %
Alternative pathway 60 30–113 %
R240H –
I300T +  
R240H +
I300T +  
R240H –
I300T –
Figure 2. Family tree. Square symbols, male sex; round symbols,
female sex; arrow, proband; green symbols, included subjects; blue
symbols, not available for inclusion.
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genetic analysis of protein S and C4BP did reveal at least
one potential pathogenic mutation in C4BPA gene
(p.R240H). Screening for these mutations in father and
one brother could not exclude the possible association
between this mutation and decreased C4BP levels.
To our knowledge, this is the third report on increased
free protein S levels due to decreased C4BP levels [14,
15]. However, this is the first study that investigated the
molecular background of this phenomenon and revealed
two previously published nonsynonymous variants in
C4BPA that seem to have no significant effect on the
overall expression of C4BPA. In the study of Comp et al.,
a family is identified with reduced C4BP levels and
increased free protein S levels [14]. However, no causes
for the reduced C4BP levels were reported. The second
study reported low C4BP levels with increased protein S
activity in neonates [15]. These authors propose that the
increased protein S activity might be physiological and
protect the newborn against thrombosis.
It remains unclear how the high protein S activity due to
decreased C4b-binding protein is related to the ischemic
retinopathy in our patient. The protein S fraction bound to
C4BP may have some anticoagulant activity, as suggested
before [4]. Perhaps the low PS/C4BP complex level has
increased the risk of arterial thrombosis in our patient.




RM, JKV, RPHMM, ABM, and MVL: performed the
research. RM, JKV, RPHMM, ABM, and MVL: designed
the research study. RM, JKV, RPHMM, ABM, and MVL:
analyzed the data. RM, JKV, RPHMM, ABM, and MVL:
wrote the paper.
References
1. Hackeng, T. M., K. M. Sere, G. Tans, and J. Rosing. 2006.
Protein S stimulates inhibition of the tissue factor pathway
by tissue factor pathway inhibitor. Proc. Natl. Acad. Sci. U
S A 103:3106–3111.
2. Sere, K. M., J. Rosing, and T. M. Hackeng. 2004.
Inhibition of thrombin generation by protein S at low
procoagulant stimuli: implications for maintenance of the
hemostatic balance. Blood 104:3624–3630.
3. Dahlb€ack, B., and J. Stenflo. 1981. High molecular weight
complex in human plasma between vitamin K-dependent
protein S and complement component C4b-binding
protein. Proc. Natl. Acad. Sci. U S A 78:2512–2516.
4. Maurissen, L. F., M. C. Thomassen, G. A. Nicolaes, B.
Dahlb€ack, G. Tans, J. Rosing, et al. 2008. Re-evaluation of
the role of the protein S-C4b binding protein complex in
activated protein C-catalyzed factor Va-inactivation. Blood
111:3034–3041.
5. Blom, A. M., B. O. Villoutreix, and B. Dahlb€ack. 2004.
Complement inhibitor C4b-binding protein-friend or foe in
the innate immune system? Mol. Immunol. 40:1333–1346.
6. H€ardig, Y., A. Rezaie, and B. Dahlb€ack. 1993. High
affinity binding of human vitamin K-dependent protein
S to a truncated recombinant beta-chain of C4b-binding
protein expressed in Escherichia coli. J. Biol. Chem.
268:3033–3036.
7. Garcıa de Frutos, P., R. I. Alim, Y. H€ardig, B. Z€oller, and
B. Dahlb€ack. 1994. Differential regulation of alpha and
beta chains of C4b-binding protein during acute-phase
response resulting in stable plasma levels of free
anticoagulant protein S. Blood 84:815–822.
8. Blom, A. M., F. Bergstr€om, M. Edey, M. Diaz-Torres, D.
Kavanagh, A. Lampe, et al. 2008. A novel non-synonymous
polymorphism (p.Arg240His) in C4b-binding protein is
associated with atypical hemolytic uremic syndrome and
leads to impaired alternative pathway cofactor activity. J.
Immunol. 180:6385–6391.
9. Martınez-Barricarte, R., E. Goicoechea de Jorge, T.
Montes, A. G. Layana, and S. Rodrıguez de Cordoba. 2009.
Lack of association between polymorphisms in C4b-
binding protein and atypical haemolytic uraemic syndrome
in the Spanish population. Clin. Exp. Immunol. 155:59–64.
10. Mohlin, F. C., E. Mercier, V. Fremeaux-Bacchi, M. K.
Liszewski, J. P. Atkinson, J. C. Gris, et al. 2013. Analysis of
genes coding for CD46, CD55, and C4b-binding protein in
patients with idiopathic, recurrent, spontaneous pregnancy
loss. Eur. J. Immunol. 43:1617–1629.
11. Carlsson, S., and B. Dahlb€ack. 2010. Dependence on
vitamin K-dependent protein S for eukaryotic cell
secretion of the beta-chain of C4b-binding protein. J. Biol.
Chem. 285:32038–32046.
12. Even€as, P., P. Garcıa De Frutos, S. Linse, and B. Dahlb€ack.
1999. Both G-type domains of protein S are required for
the high-affinity interaction with C4b-binding protein.
Eur. J. Biochem. 266:935–942.
13. Reitsma, P. H., H. K. Ploos van Amstel, and R. M.
Bertina. 1994. Three novel mutations in five unrelated
subjects with hereditary protein S deficiency type I. J. Clin.
Invest. 93:486–492.
14. Comp, P. C., J. Forristall, C. D. West, and R. G. Trapp.
1990. Free protein S levels are elevated in familial C4b-
binding protein deficiency. Blood 76:2527–2529.
15. Schwarz, H. P., W. Muntean, H. Watzke, B. Richter, and J.
H. Griffin. 1988. Low total protein S antigen but high
protein S activity due to decreased C4b-binding protein in
neonates. Blood 71:562–565.
938 ª 2018 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.
High PS activity due to C4BP deficiency R. Mulder et al.
